- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04783337
Local Remodelling of Bone Fracture Healing
Local Remodelling and Mechanoregulation of Bone Fracture Healing in Healthy, Aged, and Osteoporotic Humans
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
So far, empirical values have mainly been used to assess fracture healing. The clinical parameter used is freedom from pain over the fracture, and native radiology the callus formation. In the case of anatomically reduced fractures, however, this can hardly be observed. In the case of a distal radius fracture, it is assumed that the total time to complete healing and resilience is one year. However, this has not been proven biomechanically.
The high-resolution peripheral quantitative computed tomography offers the possibility of precisely describing the healing process in the high-resolution range using the trabecular structure, bone density, bone volume and tissue composition. The finite element analysis can then be used to calculate the load-bearing capacity of the bone and to create failure models. The distal radius fracture is one of the most common fractures in humans, especially in osteoporosis. Due to its frequency and easily accessible fracture localization, it is an ideal model for investigating fracture healing. The additional examination of blood and urine for bone loss markers can provide further information on the healing process in conjunction with the image data.
It is a prospective cohort study. The collected data are compared on the one hand with preliminary examinations of the injured side in the sense of creating a model and on the other hand with the healthy, non-fractured side in order to compare the strength of the fracture.
Performing the X-ray and HR-pQCTs leads to radiation exposure which, however, can be classified as low. (X-ray: 0.02 mSv / image; HR-pQCT: between 0.003 - 0.006 mSv / stack image). The DXA examination on the distal radius, femur / hip + lumbar spine requires 0.405 mSv. With 18 x-rays and 24 HR-pQCTs and 1 DXA per patient, there is a radiation exposure of 0.837 - 0.909 mSv over the course of the academic year.
Blood will also be taken and urine samples will be collected. Together with the clinical examination and filling in the questionnaire, each examination should take approx. 45 minutes.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 18+
- Conservatively treated distal radius fracture
- Able and agree to sign a written consent
- Able and agree to attend the follow-up examinations
- Able to understand the national language both in writing and orally to a minimum
Exclusion Criteria:
- Age under 18
- Comminuted fracture
- Bilateral spoke fracture
- unstable fracture with indication for surgical treatment
- open spoke fracture
- Adjacent fractures or injuries
- Previous injury to the distal radius
- The patient cannot give consent due to physical or mental disabilities
- Patient is not available for regular check-ups (abroad)
- The patient does not have full legal capacity
- Alcohol and drug abuse
- Current treatment with steroids
- Multiple trauma
- Illnesses or disorders that restrict the movement of a hand (apoplexy, hemiparesis, neuromuscular or rheumatic disease, severe mental or metabolic diseases)
- Rheumatoid arthritis
- Previous radio or chemotherapy within the last year
- Currently participating in a pharmaceutical study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: BASIC_SCIENCE
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: HR-pQCT (high resolution computertomograph)
This arm is the inverventional group for all collected cases. No other arms are available as comparator or control. All patients are treated the same. Description of the intervention in the section "Intervention". |
In addition to determining the bone density, a quantitative bone structure analysis with measurement of the number of thickness and distribution of the trabeculae can also be carried out.
In addition, the finite element analysis (FEA) allows strength models of the examined bone to be created from the data of the hr-pqCTs.
In this way, the osseous consolidation of the fracture can not only be observed, but also tested for resilience with the help of mathematical models.
Bone remodeling blood marker: S-CTX (Crosslaps), S-TRA5b ( tartrate-resistant acid phosphatase), S-PINP (Procollagen type 1 amino-terminal propeptide), BALP, Calcium, parathyroid hormone, 25-OH-Vitamin D3 (HPLC)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Strength analysis of the distal radius fracture
Time Frame: 1 year
|
The aim of our study is to create a mathematical model of human bone healing using the example of a distal radius fracture.
Computer-aided strength analyzes of data from hr-pqCTs should provide information about the fracture strength and quality of the newly formed bone at defined times.(finite
element analysis- FEA)
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Rate of bone density
Time Frame: 1year
|
Amount of bone mineral in bone tissue, using DXA Scan (Dual-xray absorbtiometry).
|
1year
|
Bone remodeling markers (blood analysis)
Time Frame: 1year
|
Concentration of bone remodeling markers of (sober) blood samples with signs of healing in hr-pqCT and conventional X-rays. Blood markers of bone remodeling are: S-CTX (Crosslaps), S-TRA5b ( tartrate-resistant acid phosphatase), S-PINP (Procollagen type 1 amino-terminal propeptide), BALP, Calcium, parathyroid hormone, 25-OH-Vitamin D3 (HPLC). Increaseing bone turnover values during healing period. |
1year
|
Patient Reported Outcome (function)
Time Frame: 1 year
|
Percentage of the patients with reduced or normal outcome after fractures using questionnaires like the Michigan Wrist Score in correlation of the healing process.
This is a score reporting the functional outcome, satisfaction and quality of life.
Best score is 100%, least score 0%.
|
1 year
|
Patient Reported Outcome (pain)
Time Frame: 1 year
|
Percentage of the patients with remaining pain after fracture using the visual analog scale in correlation of the healing process.
The scale reports about the intensity of pain.
The maximum pain and least score is 10, and the best score is 0 which means "no pain".
|
1 year
|
Clinical outcome (range of motion)
Time Frame: 1 year
|
Degree of the possible range of motion using a goniometer to measure the movement angles in correlation of the healing process. The better the range of motion the higher the value. Normally the following limits are given: Radial: least 0 degree, maximum: 20 degree Ulnar: least 0 degree, maximum: 40 degree Extension: least 0 degree, maximum: 70 degree Flexion: least 0 degree, maximum: 70 degree Pronation: least 0 degree, maximum: 90 degree Supination: least 0 degree, maximum: 90 degree |
1 year
|
Clinical outcome (grip strength wrist)
Time Frame: 1 year
|
Extent of possible grip strength measurement using dynanometer in correlation of the healing process. Minimum: 0 kilogram Maximum: 80 kg |
1 year
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- I-3258-B27_microCT Radius
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Distal Radius Fracture
-
University of AarhusCompletedDistal Radius Fracture | Radius Fracture Distal | Radius Distal FractureDenmark
-
University of DuhokCompletedChildren, Only | Fracture Distal RadiusIraq
-
Carlos A Acosta-OlivoRecruiting
-
Hand Surgery Associates LLCOrthopaedic Specialty Group PC, Fairfield; Touro University NevadaNot yet recruitingDistal Radius Fractures
-
Radboud University Medical CenterNot yet recruiting
-
Zimmer BiometActive, not recruitingDistal Radius Fracture | Osteotomy | Distal Ulna FractureUnited Kingdom
-
University of North Carolina, Chapel HillNot yet recruitingDistal Radius FracturesUnited States
-
Istanbul UniversityCompletedDistal Radius FracturesTurkey
-
Novadip BiosciencesPrimeVigilance; Data Investigation Company Europe (DICE)Active, not recruitingDistal Radius FracturesLuxembourg
-
Spaarne GasthuisMaasstad Hospital; Amsterdam UMCNot yet recruitingFractures, Bone | Distal Radius FracturesNetherlands
Clinical Trials on HR-pQCT (high resolution computertomograph)
-
Hospices Civils de LyonUnknown
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingBone Diseases, Metabolic | Glomerular Disease | Bone FractureUnited States
-
Centre Hospitalier Universitaire de Saint EtienneTerminated
-
Centre Hospitalier Universitaire de Saint EtienneTerminated
-
Hospices Civils de LyonCompletedLong-term Parenteral Nutrition (2 Years) in Children and AdultsFrance
-
Centre Hospitalier Universitaire de Saint EtienneCompletedChronic Kidney Diseases | Hyperparathyroidism, SecondaryFrance
-
Hospices Civils de LyonCompleted
-
University Hospital, BordeauxRecruitingEpilepsy | Parkinson DiseaseFrance
-
Centre Hospitalier Universitaire de Saint EtiennePfizerCompleted
-
AmgenCompletedOsteoporosis | Postmenopausal Osteoporosis | Low Bone Mineral Density | Low Bone Mass